Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
May 8, 2002
Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults
Johan Svensson, Jesper Fowelin, Kerstin Landin, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
November 20, 2003
Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections
Jan-Ove Johansson, Lena Wirén, Jan Oscarsson, et al.
Plos One
|
May 3, 2017
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Per Johansson, Erik G Almqvist, Anders Wallin, et al.
Neuroscience Letters
|
October 11, 2015
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease
Per Johansson, Erik G Almqvist, Anders Wallin, et al.
American Journal of Physiology. Renal Physiology
|
October 9, 2009
Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus
Mia Faerch, Jane H Christensen, Søren Rittig, et al.
Neuroendocrinology
|
June 28, 2018
A Novel Synonymous Variant in the AVP Gene Associated with Autosomal Dominant Familial Neurohypophyseal Diabetes Insipidus Causes Partial RNA Missplicing
Helene Kvistgaard, Jane H Christensen, Jan-Ove Johansson, et al.
Journal of Alzheimer'S Disease : JAD
|
February 8, 2011
Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population
Per Johansson, Niklas Mattsson, Oskar Hansson, et al.
Psychoneuroendocrinology
|
November 20, 2012
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
Per Johansson, Erik G Almqvist, Jan-Ove Johansson, et al.
Experimental Gerontology
|
January 3, 2012
Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study
Sofia Movérare-Skrtic, Per Johansson, Niklas Mattsson, et al.
Journal of Alzheimer'S Disease : JAD
|
July 13, 2017
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease
Per Johansson, Erik G Almqvist, Maria Bjerke, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Clinical Endocrinology and Metabolism
|
May 8, 2002
Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults
Johan Svensson, Jesper Fowelin, Kerstin Landin, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
November 20, 2003
Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections
Jan-Ove Johansson, Lena Wirén, Jan Oscarsson, et al.
Plos One
|
May 3, 2017
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Per Johansson, Erik G Almqvist, Anders Wallin, et al.
Neuroscience Letters
|
October 11, 2015
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease
Per Johansson, Erik G Almqvist, Anders Wallin, et al.
American Journal of Physiology. Renal Physiology
|
October 9, 2009
Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus
Mia Faerch, Jane H Christensen, Søren Rittig, et al.
Neuroendocrinology
|
June 28, 2018
A Novel Synonymous Variant in the AVP Gene Associated with Autosomal Dominant Familial Neurohypophyseal Diabetes Insipidus Causes Partial RNA Missplicing
Helene Kvistgaard, Jane H Christensen, Jan-Ove Johansson, et al.
Journal of Alzheimer'S Disease : JAD
|
February 8, 2011
Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population
Per Johansson, Niklas Mattsson, Oskar Hansson, et al.
Psychoneuroendocrinology
|
November 20, 2012
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
Per Johansson, Erik G Almqvist, Jan-Ove Johansson, et al.
Experimental Gerontology
|
January 3, 2012
Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study
Sofia Movérare-Skrtic, Per Johansson, Niklas Mattsson, et al.
Journal of Alzheimer'S Disease : JAD
|
July 13, 2017
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease
Per Johansson, Erik G Almqvist, Maria Bjerke, et al.
Page
of 3